Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study

Fig. 1

Kaplan-Meier curves for progression-free survival in all patients (A), patients with squamous cell carcinoma and adenocarcinoma (B), patients with squamous cell carcinoma and adenocarcinoma who received paclitaxel liposome based chemotherapy plus immunotherapy as first-line therapy (C), and patients who received paclitaxel liposome based chemotherapy plus immunotherapy as first-line therapy, and second- or later-line treatment (D)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us